<unk>  (INN; trade name Kynamro) is a drug used to treat homozygous familial hypercholesterolemia and is administered by subcutaneous injection. There is a serious risk of liver damage from this drug and it can only be prescribed in the context of a risk management plan.
Mipomersen
Acebutolol
Lumasiran
Eluxadoline
Mitapivat
Fabomotizole
Orlistat
Casimersen